Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)
Clinical trial NCT01405820 · COMPLETED
Trial details
- NCT number
- NCT01405820
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 290
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.